Addition of chemo-immunotherapy to standard induction chemotherapy for high-risk neuroblastoma.

Karen S. Fernandez, Amit J. Sabnis, Ruetima Titapiwatanakun, Katherine Baker, Wendy Tcheng. Addition of chemo-immunotherapy to standard induction chemotherapy for high-risk neuroblastoma. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):e22009-e22009.

2022
https://researcherprofiles.org/profile/344526484

Karen S. Fernandez, Amit J. Sabnis, Ruetima Titapiwatanakun, Katherine Baker, Wendy Tcheng